In acute kidney injury (AKI), the specific metabolic conditions induced by renal failure are obscured by many interfering factors (e.g., sepsis, pulmonary dysfunction, and hemodynamic instability). Many low-molecular-weight uremic retention solutes contribute to the uremic syndrome, but also the middle-molecular-weight molecules are an important group of biologically active uremic retention solutes. Some uremic compounds are difficult to remove by standard dialysis strategies. Increasing pore size, adding convection, and/or increasing dialysis time and frequency improve their removal. Optimal toxin removal should be one of the primary aims in the treatment of AKI. © Springer-Verlag Berlin Heidelberg 2010.
CITATION STYLE
Glorieux, G., Van Biesen, W., Lameire, N., & Vanholder, R. (2010). Uremic toxins. In Management of Acute Kidney Problems (pp. 21–31). Springer Berlin Heidelberg. https://doi.org/10.1007/978-3-540-69441-0_3
Mendeley helps you to discover research relevant for your work.